'philadelphia chromosomepositive ph3'

Dasatinib Tablet 100 Mg ₹ 2999 / Bottle Get Latest Price Product Brochure Strength 100 mg Pack Size 1*30 Tablet Pack Type Box Brand Name Sprycel Manufacturer BMS Usages chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia Country of Origin Made in India Dasatinib, sold under the brand name Sprycel among others, is a targeted therapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).[3] Specifically it is used to treat cases that are Philadelphia chromosome-positive (Ph+).[3] It is taken by mouth.[3] Common adverse effects include low white blood cells, low blood platelets, anemia, swelling, rash, and diarrhea.[3] Severe adverse effects may include bleeding, pulmonary edema, heart failure, and prolonged QT syndrome.[3] Use during pregnancy may result in harm to the baby.[3] It is a tyrosine-kinase inhibitor and works by blocking a number of tyrosine kinases such as Bcr-Abl and the Src kinase family.[3] Dasatinib was approved for medical use in the United States and in the European Union in 2006.[3][2] It is on the World Health Organization's List of Essential Medicines.[4]

150mg Knilonat Nilotinib Capsules ₹ 1199 / Box Get Latest Price Form Tablet Packaging Type Box Shelf Life 24 Months Strength 150 mg Brand Knilonat Composition Nilotinib Knilonat 150mg capsules contain nilotinib, a tyrosine kinase inhibitor, used to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, especially when other treatments have failed.